Sumona Saha1, Ying-Qi Zhao, Samir A Shah, Silvia Degli Esposti, Sheldon Lidofsky, Sana Salih, Renee Bright, Meaghan Law, Heather Moniz, Nicole Flowers, Marjorie Merrick, Bruce E Sands. 1. *Division of Gastroenterology and Hepatology, and †Department of Biostatics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; ‡Division of Gastroenterology, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island; §Division of Reproductive Endocrinology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; ‖Department of Pediatric Gastroenterology, Rhode Island Hospital, Providence, Rhode Island; ¶Division of Community Health, Centers for Disease Control and Prevention, Atlanta, Georgia; **Crohn's and Colitis Foundation of America, New York, New York; and ††Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine, Mount Sinai, New York, New York.
Abstract
BACKGROUND: The effect of the inflammatory bowel diseases (IBD) on menstrual function is largely unknown. The aims of this study were to determine whether changes in menstrual function occur in the year before IBD diagnosis or in the initial years after diagnosis. METHODS: Women aged 18 years and older in the Ocean State Crohn's and Colitis Area Registry with at least 2 years of follow-up were eligible for this study. All patients were enrolled within 6 months of IBD diagnosis and followed prospectively. Menstrual cycle characteristics were retrospectively assessed. To assess for changes over time, general linear models for correlated data were used for continuous outcomes, and generalized estimating equations were used for discrete outcomes. RESULTS: One hundred twenty-one patients were studied. Twenty-five percent of patients experienced a change in cycle interval in the year before IBD diagnosis and 21% experienced a change in the duration of flow. Among women with dysmenorrhea, 40% experienced a change in the intensity of their menstrual pain and 31% experienced a change in its duration. Overall cycle regularity increased over time. Quality of life was significantly lower in women without regular cycles across all time points. CONCLUSIONS: Changes in menstrual function occur frequently in the year before IBD diagnosis; therefore, screening for menstrual irregularities should be considered in women with newly diagnosed IBD. Patients can be reassured that cycles typically become more regular over time.
BACKGROUND: The effect of the inflammatory bowel diseases (IBD) on menstrual function is largely unknown. The aims of this study were to determine whether changes in menstrual function occur in the year before IBD diagnosis or in the initial years after diagnosis. METHODS:Women aged 18 years and older in the Ocean State Crohn's and Colitis Area Registry with at least 2 years of follow-up were eligible for this study. All patients were enrolled within 6 months of IBD diagnosis and followed prospectively. Menstrual cycle characteristics were retrospectively assessed. To assess for changes over time, general linear models for correlated data were used for continuous outcomes, and generalized estimating equations were used for discrete outcomes. RESULTS: One hundred twenty-one patients were studied. Twenty-five percent of patients experienced a change in cycle interval in the year before IBD diagnosis and 21% experienced a change in the duration of flow. Among women with dysmenorrhea, 40% experienced a change in the intensity of their menstrual pain and 31% experienced a change in its duration. Overall cycle regularity increased over time. Quality of life was significantly lower in women without regular cycles across all time points. CONCLUSIONS: Changes in menstrual function occur frequently in the year before IBD diagnosis; therefore, screening for menstrual irregularities should be considered in women with newly diagnosed IBD. Patients can be reassured that cycles typically become more regular over time.
Authors: Audra L Gollenberg; Mary L Hediger; Sunni L Mumford; Brian W Whitcomb; Kathleen M Hovey; Jean Wactawski-Wende; Enrique F Schisterman Journal: J Womens Health (Larchmt) Date: 2010-05 Impact factor: 2.681
Authors: Jason M Shapiro; Helga Zoega; Samir A Shah; Renee M Bright; Meaghan Mallette; Heather Moniz; Stacey A Grabert; Barbara Bancroft; Marjorie Merrick; Nicole T Flowers; Zahid Samad; Sheldon Lidofsky; Neal S LeLeiko; Bruce E Sands Journal: Inflamm Bowel Dis Date: 2016-06 Impact factor: 5.325
Authors: Andrew Y F Li Yim; Nicolette W Duijvis; Jing Zhao; Wouter J de Jonge; Geert R A M D'Haens; Marcel M A M Mannens; Adri N P M Mul; Anje A Te Velde; Peter Henneman Journal: Clin Epigenetics Date: 2016-06-08 Impact factor: 6.551
Authors: Janine van der Giessen; Vivian W Huang; C Janneke van der Woude; Gwenny M Fuhler Journal: Clin Transl Gastroenterol Date: 2019-03 Impact factor: 4.488